Clinical Trials · NCT05199714

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes

Name: A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/APramlintide

Phase: N/A
Recruitment status: Completed
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Enrollment: 12
Start date: Feb 2022
Locations: 1 site, Canada
Primary endpoint: Each participant's percentage of time glucose levels spent in the target range

View Pramlintide compound reference